Lexaria enters definitive agreements for immediate warrant exercises
Lexaria Bioscience said it entered definitive agreements for the immediate exercise of certain outstanding warrants, targeting approximately $5.9 million in gross proceeds.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.